Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Table of Contents

01 December 2018; volume 52, issue 6

Editorials

  • You have accessRestricted access
    Current clinical management of smoke inhalation injuries: a reality check
    Arietta Spinou, Nikolaos G. Koulouris
    European Respiratory Journal 52 (6) 1802163; DOI: 10.1183/13993003.02163-2018 Published 6 December 2018
  • You have accessRestricted access
    The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration
    Peter D. Sly, Zoltán Hantos on behalf of the INCIRCLE Clinical Research Collaboration
    European Respiratory Journal 52 (6) 1801867; DOI: 10.1183/13993003.01867-2018 Published 13 December 2018
  • You have accessRestricted access
    The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration
    Steve Cunningham, Carlee Gilbert, Nico Schwerk on behalf of the ChILDEU Clinical Research Collaboration Management Committee
    European Respiratory Journal 52 (6) 1801855; DOI: 10.1183/13993003.01855-2018 Published 6 December 2018
  • You have accessRestricted access
    Inhaled corticosteroids in COPD: the final verdict is…
    Janice M. Leung, Don D. Sin
    European Respiratory Journal 52 (6) 1801940; DOI: 10.1183/13993003.01940-2018 Published 13 December 2018
  • You have accessRestricted access
    Triple therapy trials in COPD: a precision medicine opportunity
    Samy Suissa, Amnon Ariel
    European Respiratory Journal 52 (6) 1801848; DOI: 10.1183/13993003.01848-2018 Published 13 December 2018
  • You have accessRestricted access
    Letting the right one in: evaluating the generalisability of clinical trials
    Rahul Shrimanker, Richard Beasley, Ciléin Kearns
    European Respiratory Journal 52 (6) 1802218; DOI: 10.1183/13993003.02218-2018 Published 13 December 2018
  • You have accessRestricted access
    Dropping acid: why is cystic fibrosis mucus abnormal?
    Bruce K. Rubin, David J. Thornton
    European Respiratory Journal 52 (6) 1802057; DOI: 10.1183/13993003.02057-2018 Published 6 December 2018
  • You have accessRestricted access
    Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end
    Marlies S. Wijsenbeek, Mirjam Kool, Vincent Cottin
    European Respiratory Journal 52 (6) 1802111; DOI: 10.1183/13993003.02111-2018 Published 13 December 2018
  • You have accessRestricted access
    Palliative care for patients with pulmonary fibrosis: symptom relief is essential
    Kathleen Lindell, Ganesh Raghu
    European Respiratory Journal 52 (6) 1802086; DOI: 10.1183/13993003.02086-2018 Published 6 December 2018
  • You have accessRestricted access
    New short regimens for latent tuberculosis treatment: safety first!
    Dick Menzies, Anete Trajman
    European Respiratory Journal 52 (6) 1802180; DOI: 10.1183/13993003.02180-2018 Published 20 December 2018

ERS Official Documents

  • ERS statement

    • You have accessRestricted access
      ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe
      Anna L. Rich, David R. Baldwin, Paul Beckett, Thierry Berghmans, Jeanette Boyd, Corinne Faivre-Finn, Françoise Galateau-Salle, Fernando Gamarra, Bogdan Grigoriu, Niels-Christian G. Hansen, Georgia Hardavella, Erik Jakobsen, Dragana Jovanovic, Assia Konsoulova, Gilbert Massard, John McPhelim, Anne-Pascale Meert, Robert Milroy, Luciano Mutti, Marianne Paesmans, Michael D. Peake, Paul Martin Putora, Dirk K.M. de Ruysscher, Jean-Paul Sculier, Arnaud Scherpereel, Dragan R. Subotic, Paul Van Schil, Torsten Gerriet Blum
      European Respiratory Journal 52 (6) 1800610; DOI: 10.1183/13993003.00610-2018 Published 20 December 2018

Original Articles

  • Lung cancer

    • Open Access
      Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer
      Christine M. Cramer-van der Welle, Bas J.M. Peters, Franz M.N.H. Schramel, Olaf H. Klungel, Harry J.M. Groen, Ewoudt M.W. van de Garde for the Santeon NSCLC Study Group
      European Respiratory Journal 52 (6) 1801100; DOI: 10.1183/13993003.01100-2018 Published 20 December 2018
    • You have accessRestricted access
      Variable radiological lung nodule evaluation leads to divergent management recommendations
      Arjun Nair, Emily C. Bartlett, Simon L.F. Walsh, Athol U. Wells, Neal Navani, Georgia Hardavella, Sanjeev Bhalla, Lucio Calandriello, Anand Devaraj, Jin Mo Goo, Jeffrey S. Klein, Heber MacMahon, C.M. Schaefer-Prokop, Joon-Beom Seo, Nicola Sverzellati, Sujal R. Desai and the Lung Nodule Evaluation Group
      European Respiratory Journal 52 (6) 1801359; DOI: 10.1183/13993003.01359-2018 Published 20 December 2018
  • Asthma

    • You have accessRestricted access
      Randomised controlled trials in severe asthma: selection by phenotype or stereotype
      Thomas Brown, Thomas Jones, Kerry Gove, Clair Barber, Scott Elliott, Anoop Chauhan, Peter Howarth on behalf of the Wessex Severe Asthma Cohort (WSAC) team
      European Respiratory Journal 52 (6) 1801444; DOI: 10.1183/13993003.01444-2018 Published 13 December 2018
  • Cystic fibrosis

    • You have accessRestricted access
      Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH
      David B. Hill, Robert F. Long, William J. Kissner, Eyad Atieh, Ian C. Garbarine, Matthew R. Markovetz, Nicholas C. Fontana, Matthew Christy, Mehdi Habibpour, Robert Tarran, M. Gregory Forest, Richard C. Boucher, Brian Button
      European Respiratory Journal 52 (6) 1801297; DOI: 10.1183/13993003.01297-2018 Published 6 December 2018
  • Interstitial lung diseases

    • You have accessRestricted access
      SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
      Ganesh Raghu, Luca Richeldi, Bruno Crestani, Peter Wung, Raphael Bejuit, Corinne Esperet, Christian Antoni, Christina Soubrane
      European Respiratory Journal 52 (6) 1801130; DOI: 10.1183/13993003.01130-2018 Published 13 December 2018
    • You have accessRestricted access
      Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study
      Sabrina Bajwah, Joanna M. Davies, Hanan Tanash, David C. Currow, Adejoke O. Oluyase, Magnus Ekström
      European Respiratory Journal 52 (6) 1801278; DOI: 10.1183/13993003.01278-2018 Published 6 December 2018
  • Tuberculosis

    • You have accessRestricted access
      Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study
      Lei Gao, Haoran Zhang, Henan Xin, Jianmin Liu, Shouguo Pan, Xiangwei Li, Ling Guan, Fei Shen, Zisen Liu, Dakuan Wang, Xueling Guan, Jiaoxia Yan, Hengjing Li, Boxuan Feng, Xuefang Cao, Yu Chen, Wei Cui, Zongde Zhang, Yu Ma, Xiaoyou Chen, Xinhua Zhou, Qi Jin for the LATENTTB-NSTM study team
      European Respiratory Journal 52 (6) 1801470; DOI: 10.1183/13993003.01470-2018 Published 20 December 2018
    • You have accessRestricted access
      Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia
      Katie Dorothy Dale, James McCracken Trauer, Pete J. Dodd, Rein M.G.J. Houben, Justin Timothy Denholm
      European Respiratory Journal 52 (6) 1801218; DOI: 10.1183/13993003.01218-2018 Published 20 December 2018
    • You have accessRestricted access
      High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
      Norbert Ndjeka, Kathryn Schnippel, Iqbal Master, Graeme Meintjes, Gary Maartens, Rodolfo Romero, Xavier Padanilam, Martin Enwerem, Sunitha Chotoo, Nalini Singh, Jennifer Hughes, Ebrahim Variava, Hannetjie Ferreira, Julian te Riele, Nazir Ismail, Erika Mohr, Nonkqubela Bantubani, Francesca Conradie
      European Respiratory Journal 52 (6) 1801528; DOI: 10.1183/13993003.01528-2018 Published 20 December 2018
    • You have accessRestricted access
      Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes
      Simon M. Collin, Gerard de Vries, Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Sarah R. Anderson, Dominik Zenner
      European Respiratory Journal 52 (6) 1801449; DOI: 10.1183/13993003.01449-2018 Published 6 December 2018
  • Allergy and basic science

    • You have accessRestricted access
      Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression
      Koen Van Crombruggen, Sylvie Taveirne, Gabriele Holtappels, Georges Leclercq, Claus Bachert
      European Respiratory Journal 52 (6) 1800742; DOI: 10.1183/13993003.00742-2018 Published 6 December 2018

Reviews

  • You have accessRestricted access
    Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
    Mario Cazzola, Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera
    European Respiratory Journal 52 (6) 1801586; DOI: 10.1183/13993003.01586-2018 Published 13 December 2018
  • You have accessRestricted access
    Inhaled corticosteroids in COPD: friend or foe?
    Alvar Agusti, Leonardo M. Fabbri, Dave Singh, Jørgen Vestbo, Bartolome Celli, Frits M.E. Franssen, Klaus F. Rabe, Alberto Papi
    European Respiratory Journal 52 (6) 1801219; DOI: 10.1183/13993003.01219-2018 Published 13 December 2018

Series

  • You have accessRestricted access
    What is early COPD and why is it important?
    Joan B. Soriano, Francesca Polverino, Borja G. Cosio
    European Respiratory Journal 52 (6) 1801448; DOI: 10.1183/13993003.01448-2018 Published 6 December 2018

Agora

  • Research letters

    • You have accessRestricted access
      The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model
      Martina Gentzsch, Deborah M. Cholon, Nancy L. Quinney, Susan E. Boyles, Mary E.B. Martino, Carla M.P. Ribeiro
      European Respiratory Journal 52 (6) 1801133; DOI: 10.1183/13993003.01133-2018 Published 20 December 2018
    • You have accessRestricted access
      Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia
      Cécile Rotenberg, Valérie Besnard, Pierre-Yves Brillet, Stéphane Giraudier, Hilario Nunes, Dominique Valeyre
      European Respiratory Journal 52 (6) 1801482; DOI: 10.1183/13993003.01482-2018 Published 20 December 2018
    • You have accessRestricted access
      Inhaled corticosteroid containing combinations and mortality in COPD
      Jørgen Vestbo, Leonardo Fabbri, Alberto Papi, Stefano Petruzzelli, Mario Scuri, Alessandro Guasconi, Stefano Vezzoli, Dave Singh
      European Respiratory Journal 52 (6) 1801230; DOI: 10.1183/13993003.01230-2018 Published 13 December 2018
    • You have accessRestricted access
      Exacerbations of severe asthma in patients treated with mepolizumab
      Rahul Shrimanker, Ian D. Pavord, Steve Yancey, Liam G. Heaney, Ruth H. Green, Peter Bradding, Beverley Hargadon, Chris E. Brightling, Andrew J. Wardlaw, Pranabashis Haldar
      European Respiratory Journal 52 (6) 1801127; DOI: 10.1183/13993003.01127-2018 Published 13 December 2018
    • You have accessRestricted access
      A systematic review of clinical trial registration in major respiratory journals 2010–2018
      Nelli S.M. Suntila, Alexandria Smith, Yusuf Al-Dabbagh, James D. Chalmers
      European Respiratory Journal 52 (6) 1801491; DOI: 10.1183/13993003.01491-2018 Published 6 December 2018
    • You have accessRestricted access
      Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry
      Frederikus A. Klok, Stefano Barco, Stavros V. Konstantinides, Philippe Dartevelle, Elie Fadel, David Jenkins, Nick H. Kim, Michael Madani, Hiromi Matsubara, Eckhard Mayer, Joanna Pepke-Zaba, Marion Delcroix, Irene M. Lang
      European Respiratory Journal 52 (6) 1801687; DOI: 10.1183/13993003.01687-2018 Published 6 December 2018
  • Correspondence

    • You have accessRestricted access
      Challenges in interpreting trends in testing for α1-antitrypsin deficiency in COPD patients from UK primary care
      Daniel R. Morales
      European Respiratory Journal 52 (6) 1801986; DOI: 10.1183/13993003.01986-2018 Published 20 December 2018
    • You have accessRestricted access
      Challenges in interpreting trends in testing for α1-antitrypsin deficiency in COPD patients from UK primary care
      Joan B. Soriano on behalf of all co-authors
      European Respiratory Journal 52 (6) 1802064; DOI: 10.1183/13993003.02064-2018 Published 20 December 2018
    • You have accessRestricted access
      Improving the management of spontaneous pneumothorax
      Uri Kartoun
      European Respiratory Journal 52 (6) 1801857; DOI: 10.1183/13993003.01857-2018 Published 6 December 2018
    • You have accessRestricted access
      Improving the management of spontaneous pneumothorax
      José M. Porcel
      European Respiratory Journal 52 (6) 1801918; DOI: 10.1183/13993003.01918-2018 Published 6 December 2018

Author Correction

  • You have accessRestricted access
    “Physical activity as a moderator for obstructive sleep apnoea and cardiometabolic risk in the EPISONO study.” Marcos Mônico-Neto, Hanna Karen Moreira Antunes, Ronaldo Vagner Thomatieli dos Santos, Vânia D'Almeida, Altay Alves Lino de Souza, Lia Rita Azeredo Bittencourt and Sergio Tufik. Eur Respir J 2018; 52: 1701972.
    European Respiratory Journal 52 (6) 1751972; DOI: 10.1183/13993003.51972-2017 Published 13 December 2018
Back to top
PreviousNext
European Respiratory Journal: 52 (6)
  • Table of Contents
  • Index by author

Search Within This Issue

Jump to

  • Editorials
  • ERS Official Documents
    • ERS statement
  • Original Articles
    • Lung cancer
    • Asthma
    • Cystic fibrosis
    • Interstitial lung diseases
    • Tuberculosis
    • Allergy and basic science
  • Reviews
  • Series
  • Agora
    • Research letters
    • Correspondence
  • Author Correction
Manage Table of content Alerts
  • Most Read
  • Twitter
Loading
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • ERS clinical practice guidelines on treatment of sarcoidosis
  • Lung volumes and forced ventilatory flows
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society